Diabetes, Gestational: Clinical Trials

32 trials for Diabetes, Gestational, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 6 unknown, 3 recruiting, 3 terminated. 32 Phase 3, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 332Completed 19, Unknown 6, Recruiting 3, Terminated 3, Not yet recruiting 1
Phase 29Completed 5, Unknown 3, Not yet recruiting 1

Follow Diabetes, Gestational: new trials by email Literature Review of Diabetes, Gestational trials Research Report on Diabetes, Gestational

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus
Semaglutide (Wegovy) weekly injection - Gestational Diabetes Mellitus (GDM), Metabolic Syndrome
Phase 2 / Phase 3Not yet recruitingUniversity of Massachusetts, Worcester2262027-09-012026-09-28
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
Inhaled Technosphere Insulin - Diabetes, Gestational, Pregnancy Complications
Phase 2 / Phase 3CompletedJaeb Center for Health Research302025-06-022026-10-19
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Insulin glargine, insulin NPH - Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM)
Phase 3RecruitingLoyola University1602024-04-012024-10-01
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
Semaglutide Pen Injector, Semaglutide placebo - Glucose Intolerance After a Recent History of Gestational Diabetes
Phase 3RecruitingUniversitaire Ziekenhuizen KU Leuven2522023-09-142026-09-15
A Pragmatic Approach to Lower Diabetes Risk After Gestational Diabetes
Metformin - Diabetes, Gestational, PreDiabetes
Phase 3CompletedTufts Medical Center202022-06-012025-04-20
Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation
500 mg of ursodeoxycholic acid (UDCA), 500 mg of Placebo - Gestational Diabetes
Phase 3CompletedFundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia1132021-03-032023-11-14
A Pragmatic Approach to Lowering the Risk of Diabetes Mellitus After A Diagnosis of Gestational Diabetes Mellitus
Metformin - Gestational Diabetes
Phase 3UnknownWomen and Infants Hospital of Rhode Island2002020-11-152020-11-04
Pregnancy Outcomes: Effects of Metformin Study (POEM Study)
Metformin TEVA 850 mg - Gestational Diabetes, Insulin Resistance
Phase 3RecruitingBethesda Diabetes Research Center5002019-11-262022-02-10
PRP Use in Diabetic Patients Undergoing Cesarean Section
PRP - Diabetes, Gestational, Wound Complication
Phase 2 / Phase 3UnknownMinia University1002018-08-012018-07-27
Empagliflozin and the Preservation of Beta-cell Function in Women with Recent Gestational Diabetes
Empagliflozin 10 MG, Placebo oral capsule - Gestational Diabetes
Phase 3CompletedMount Sinai Hospital, Canada912018-07-012025-03-07
Maternal Weight Gain in Gestational Diabetes Controlled by Metformin Versus Insulin
Insulin, Metformin, Assessment of weight gain - Gestational Diabetes
Phase 3CompletedAin Shams University1242018-02-012019-02-15
Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus
Insulin, Metformin - Gestational Diabetes
Phase 3TerminatedWomen and Infants Hospital of Rhode Island12018-01-032020-07-24
RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects
Metformin Hydrochloride, Placebo - Gestational Diabetes
Phase 3CompletedNational University of Ireland, Galway, Ireland5352017-06-062025-03-17
Randomization of Early Diabetes Screening Among Obese Pregnant Women.
Screening for diabetes with 1-hour GCT and HbA1 - Gestational Diabetes
Phase 3TerminatedUniversity of Illinois at Chicago6002017-03-192020-03-03
MeDiGes Study: Metformine Use in Gestational Diabetes
Metformin, Insulin Detemir - Diabetes, Gestational, Perinatal Disorder
Phase 3UnknownFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud2002016-10-262020-05-15
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
40% Dextrose gel - Hypoglycemia, Infant, Small for Gestational Age
Phase 2 / Phase 3CompletedBaylor College of Medicine2362016-07-012025-01-08
Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus
Metformin, Insulin - Gestational Diabetes Mellitus in Pregnancy
Phase 3CompletedServices Institute of Medical Sciences, Pakistan2782016-02-012017-10-27
Metformin for Prevention Gestational Diabetes in Pregnant Women With Polycystic Ovarian Syndrome
metformin, placebo (folic acid ) - Polycystic Ovary Syndrome, Diabetes, Gestational
Phase 2 / Phase 3UnknownAin Shams University802016-01-012016-06-16
Glycemic Objectives of Women With Gestational Diabetes Mellitus
Normal glycemic control, Low glycemic control - Gestational Diabetes Mellitus
Phase 3TerminatedUniversité de Sherbrooke52015-03-012018-05-03
Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus
Metformin, control diet - Gestational Diabetes Mellitus
Phase 3CompletedMaasstad Hospital4002014-10-082026-10-09

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus (6)  ·  Diabetes Mellitus, Type 2 (6)  ·  Insulin Resistance (6)  ·  Pregnancy Complications (3)  ·  Hypoglycemia (2)  ·  Metabolic Syndrome (2)  ·  Obesity (2)  ·  Polycystic Ovary Syndrome (2)  ·  Abortion, Spontaneous (1)  ·  Birth Weight (1)  ·  Fetal Growth Retardation (1)  ·  Fetal Macrosomia (1)  ·  Glucose Intolerance (1)  ·  Glucose Metabolism Disorders (1)

Broader conditions

Endocrine System Diseases (32)  ·  Female Urogenital Diseases and Pregnancy Complications (32)  ·  Metabolic Diseases (32)  ·  Nutritional and Metabolic Diseases (32)  ·  Urogenital Diseases (32)  ·  Glucose Metabolism Disorders (31)  ·  Pregnancy Complications (29)  ·  Diabetes Mellitus (26)  ·  Hyperinsulinism (7)  ·  Body Weight (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Adnexal Diseases (2)  ·  Cysts (2)  ·  Female Urogenital Diseases (2)

Interventions

Metformin (16)  ·  Insulin (10)  ·  Glyburide (3)  ·  Insulin, Isophane (2)  ·  semaglutide (2)  ·  Behavior Therapy (1)  ·  Exercise (1)  ·  Folic Acid (1)  ·  Glycated Hemoglobin (1)  ·  Glycemic Index (1)  ·  Insulin Aspart (1)  ·  Insulin Detemir (1)  ·  Insulin Glargine (1)  ·  Insulin, Regular, Human (1)  ·  Isophane Insulin, Human (1)

Sponsors

Ain Shams University (2)  ·  University of Oulu (2)  ·  Université de Sherbrooke (2)  ·  Women and Infants Hospital of Rhode Island (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Baylor College of Medicine (1)  ·  Bethesda Diabetes Research Center (1)  ·  Dow University of Health Sciences (1)  ·  Epsom and St Helier University Hospitals NHS Trust (1)  ·  Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (1)  ·  Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (1)  ·  Jaeb Center for Health Research (1)  ·  Loyola University (1)  ·  Maasstad Hospital (1)  ·  Minia University (1)

Countries

United States (10)  ·  Canada (4)  ·  Egypt (2)  ·  Finland (2)  ·  Netherlands (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  France (1)  ·  Ireland (1)  ·  Israel (1)  ·  Italy (1)  ·  Pakistan (1)  ·  Spain (1)

Top investigators

Jean-Luc Ardilouze, MD, PhD (2)  ·  Adriaan Kooy, Dr. (1)  ·  Amy Valent, DO (1)  ·  Boaz Sheizaf, MD (1)  ·  Christopher Nau, MD (1)  ·  Dr Jyoti Balani, MD (1)  ·  Dr Ranjit Akolekar (1)  ·  Dr Steve Hyer, MD, FRCP (1)  ·  Erika Werner (1)  ·  Erika Werner, MD (1)  ·  Hilkka Ijas, MD (1)  ·  Jane E Norman, MD (1)

Results publications

PMID 12502678, PMID 17888133, PMID 21083860, PMID 23122829, PMID 25646328, PMID 25874236, PMID 26840133, PMID 28938877, PMID 29605395, PMID 29715355, PMID 31227287, PMID 32046931, PMID 35354633, PMID 36131291, PMID 37786390, PMID 39215812, PMID 40964955, PMID 42493207

NIH funding

2008 (1), 2014 (1)